Recurrent CCND3 mutations have been reported in MLL-rearranged AML, and consistent with our results high CCDN3 expression in MLL and low CCND3 expression in t(8;21) has been reported previously. This evidence concerns the gene KMT2A and acute myeloid leukemia.